BACKGROUND: Acute graft-versus-host disease (aGvHD) is a common complication of
allogeneic stem cell transplantation. It is usually treated with high doses of corticosteroids …

Importance Chronic graft-vs-host disease (GVHD) affects 50% to 70% of patients who
receive allogeneic hematopoietic cell transplants (HCTs), and the skin is the most common …

Extracorporeal photochemotherapy (ECP) is an immunotherapy that has found a role in the
therapy of cutaneous T cell lymphoma, a disease of mature activated T cells. Graft-versus …

The potentially beneficial effect of 8-methoxypsoralen and ultraviolet A (PUVA) irradiation for
treatment of drug-resistant cutaneous manifestations of graft-versus-host disease led us to …

Graft-versus-host disease (GVHD) is an immunological reaction and a frequent complication
following allogeneic hematopoietic stem cell transplantation. It is associated with high …

Graft‐versus‐host disease (GVHD) is the major complication of hematopoietic stem cell
transplantation and is associated with high mortality in severe cases. The skin is one of the …

Background Graft‐versus‐host disease (GVHD) represents an important complication
following allogeneic bone marrow transplantation. In recent years, narrowband ultraviolet B …

Background Cytokines derived from T helper (Th) 1 lymphocytes are thought to be involved
in the pathogenesis of graft‐versus‐host disease (GVHD) and extracorporeal photopheresis …

Background aims: Corticosteroids are the standard first-line treatment for acute graft-versus-
host disease (aGVHD), but they are associated with many complications, and less than half …

Hematopoietic stem-cell transplantation using cells obtained from peripheral blood, bone
marrow, or cord blood is being used to treat not only genetic and immunologic diseases, but …